Shi Bing

Chief Physician; Doctor of Medicine; Master's Supervisor; President, Beijing Lidu Medical Aesthetic Hospital. Standing Council Member, Chinese Non-government Medical Institutions Association (CNMIA); Chair, Plastic and Aesthetics Committee, Chinese Non-government Medical Institutions Association (CNMIA).
More than 30 years of experience in plastic and aesthetic surgery. In recent years, his work has focused primarily on theories of minimally invasive facial rejuvenation, biomaterials research, and combined-treatment pathways. Specializes in combined facial rejuvenation treatments, revision procedures, and body contouring. As an advocate for industry standardization, he organized the development of “Evaluation of the ability of social plastic surgery and cosmetology institutions” in 2020; led the development of “Specification of operating techniques for facial embeded thread lift” in 2023, described in the source as the first such standard in China and internationally; and led the development of “Specification of Facial Injection Techniques for Tissue Extraction Collagen” in 2024, promoting evidence-based and standardized application of minimally invasive facial rejuvenation techniques. Chief Editor of “Application of PPDO Thread Lift in Facial Rejuvenation”, “Aesthetic Thread Technology for Facial Rejuvenation and Body Shaping”, and “Standardized Application of New Materials and Technologies for Minimally Invasive Facial Rejuvenation”; author of 14 guidelines/consensus papers.
FIMAN Global Lead Tutor. Participated in drafting the group standard “Specification of Facial Injection Techniques for Tissue Extraction Collagen”, published in an SCI-indexed journal under the title “Operational Standard for Tissue-Extracted Collagen Facial Injection Techniques”; FIMAN was a participating drafting company.

